• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Timothy Annett

Stay informed with Timothy Annett’s coverage and analysis for Coins2Day.

  • Biogen headquartersHealth

    Biogen slashes cost of Alzheimer’s drug by 50% six months after FDA approval

    By Timothy Annett and Bloomberg
  • A vial of the Moderna COVID-19 Vaccine as people from ages 25 to 30 start their vaccination phase with the Moderna novel COVID-19 vaccine against the Coronavirus disease in Medellin – Antioquia, Colombia on August 2, 2021.Health

    Moderna says COVID-19 vaccine for kids under 12 showed strong results

    By Timothy Annett and Bloomberg
  • 17 June 2021, Baden-Wuerttemberg, Tübingen: A sign with the logo of the biopharmaceutical company Curevac stands in front of the company’s headquarters in Tübingen. According to an interim analysis, the efficacy of Curevac’s vaccine candidate CVnCoV is significantly lower than that of other already approved Corona vaccines.        (to dpa “Curevac disappoints with low efficacy of Corona vaccine”) Photo: Bernd Weißbrod/dpa (Photo by Bernd Weissbrod/picture alliance via Getty Images)Health

    CureVac stock tumbles after its mRNA vaccine falls well short of Pfizer and Moderna rivals

    By Timothy Annett, Tim Loh, and others
  • The participant in the AstraZeneca trial who died had not received the shot, according to reports.Health

    Participant who died in AstraZeneca trial had not been given vaccine

    By Timothy Annett, Walter Brandimarte, and others
  • Refill pods for Juul Labs Inc. e-cigarettes are displayed for sale at a store in Princeton, Illinois, U.S., on Monday, Sept. 16, 2019. Faced with a worsening epidemic of teenage vaping and a mysterious illness stalking users of cigarette alternatives, the Trump administration promised to ratchet up its oversight of a burgeoning but increasingly troubled industry. Photographer: Daniel Acker/Bloomberg via Getty ImagesLeadership

    Juul CEO Is Stepping Down As Vaping Takes a Beating

    By Timothy Annett and Bloomberg
  • WalmartRetail

    Walmart Will Stop Selling E-Cigarettes After Current Inventory Is Exhausted

    By Matthew Boyle, Timothy Annett, and others
  • The drug giant will merge its off-patent unit with generic drug company Mylan.Health

    Generic Drug Industry Sees New Giant as Pfizer Merges Off-Patent Unit With Mylan

    By Timothy Annett, Riley Ray Griffin, and others
    Rankings
    • 100 Best Companies
    • Coins2Day 500
    • Global 500
    • Coins2Day 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Coins2Day Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Coins2Day Brand Studio
    • Coins2Day Analytics
    • Coins2Day Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Coins2Day
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.